Using the neutrophil‐to‐lymphocyte ratio to predict the outcome of individuals with nonsquamous non‐small cell lung cancer receiving pembrolizumab plus platinum and pemetrexed. - Imai, Hisao; Wasamoto, Satoshi; Tsuda, Takeshi; Nagai, Yoshiaki; Kishikawa, Takayuki; Masubuchi, Ken; Osaki, Takashi; Miura, Yosuke; Umeda, Yukihiro; Ono, Akihiro; Minemura, Hiroyuki; Yamada, Yutaka; et al. (Thoracic Cancer, 2023)